Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

2021184 citationsJournal Articlehybrid Open Access

Authors

Michael A. Thompson · Aurora Health Care

Jeffrey P. Henderson · Washington University in St. Louis

Pankil Shah · Mays Cancer Center at UT Health San Antonio

Samuel M. Rubinstein · UNC Lineberger Comprehensive Cancer Center

Michael J. Joyner · Mayo Clinic

Toni K. Choueiri · Dana-Farber Cancer Institute

Daniel Flora

Abstract

The findings of this cohort study suggest a potential survival benefit in the administration of convalescent plasma to patients with hematologic cancers and COVID-19.

Topics & Keywords

COVID-19 and healthcare impacts COVID-19 Clinical Research Studies COVID-19 and Mental Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 7, Issue 8, pp. 1167-1167

DOI: 10.1001/jamaoncol.2021.1799

Field-Weighted Citation Impact: 15.11